+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Narcolepsy Therapeutics Market Size, Share & Trends Analysis Report By Treatment (Narcolepsy With Cataplexy, Secondary Narcolepsy), By Product (Sodium Oxybate, Tricyclic Antidepressants), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • August 2023
  • Region: Global
  • Grand View Research
  • ID: 5876168
Description Jump to:
The global narcolepsy therapeutics market size is expected to reach USD 6.01 billion by 2030, growing at a CAGR of 7.85% from 2023 to 2030. The increasing awareness about this sleep disorder among the public and healthcare providers is a key factor contributing to the market growth. Government and non-government bodies are conducting awareness programs and campaigns to educate people and healthcare professionals to manage the disease globally.

High unmet requirement for disease treatment is encouraging market players to develop and introduce novel therapeutic products in the market. Market players have invested significantly in understanding narcolepsy in recent years. Therefore, the approval of new effective drugs such as Wakix and Lumryz is expected to drive market growth. Moreover, special designations grants for pipeline drugs are further motivating pharmaceutical companies to invest in the development of novel drugs. For instance, Axsome Therapeutics, Inc. has AXS-12 in a phase-3 clinical study. It is being investigated for sleep disorders, both cataplexy and EDS. Moreover, AXS-12 received the U. S. FDA Orphan Drug designation for the treatment.

The landscape of treatment for the disease is expected to evolve rapidly. According to the American Journal of Managed Care, technological advancements in drug development processes are making neurological diseases an attractive therapeutic area for drug manufacturers. Hence, an increase in R&D activities related to the disease is anticipated over the forecast period. For instance, in April 2023, Zevra Therapeutics, Inc. submitted an Investigational New Drug (IND) application to the U. S. FDA to initiate a phase-1 clinical trial of KP1077 in narcolepsy.

The Narcolepsy Network has estimated that 1 out of every 2,000 people is afflicted by this condition. Moreover, Narcolepsy UK states that approximately 25% of patients are identified and the remaining 75% are untreated as they remain undiagnosed or are misdiagnosed, which is alarming. Some organizations and networks are constantly working to spread awareness about this condition among patients and physicians.

Narcolepsy Therapeutics Market Report Highlights

  • The narcolepsy therapeutics industry is anticipated to grow substantially owing to the worldwide increasing incidence of this disorder and increasing awareness among people
  • Based on treatment, the narcolepsy with cataplexy segment held the largest revenue share of 54.28% in 2022. It is expected to dominate the market throughout the forecast period owing to the rising cases of cataplexy in patients suffering from narcolepsy
  • Based on product, sodium oxybate dominated the product segment in terms of revenue share of 46.70% in the year 2022. Drugs belonging to this class have higher costs and favorable coverage policies
  • In terms of region, North America dominated the market with a revenue share of 38.03% in 2022 because of increased R&D programs, improved healthcare infrastructure, and better reimbursement policies
  • The Asia Pacific region is anticipated to exhibit the fastest CAGR of 10.37% during the forecast period owing to the rising healthcare expenditure in this region, rising awareness among people, increasing prevalence of disease, and presence of emerging economies such as China & India
  • New product launches and mergers & acquisitions are strategic initiatives undertaken by key players in the market in an attempt to remain competitive. In addition, companies are expanding their geographical presence to untapped markets

Table of Contents

Chapter 1 Report Scope and Objectives
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Treatment segment
1.1.1.2 Product segment
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Internal Database
1.6.3 Secondary Sources
1.6.4 Primary research
1.7 Information or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Treatment
2.2.2 Product
2.2.5 Region
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.2 Narcolepsy Therapeutics Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing global prevalence of narcolepsy
3.2.1.2 Narcolepsy awareness programs and services
3.2.1.3 Presence of reimbursement policies regarding narcolepsy
3.2.2 Market Restraint Analysis
3.2.2.1 Adverse effects and risks related to narcolepsy drugs
3.2.2.2 Delayed diagnosis or misdiagnosis
3.3 Narcolepsy Therapeutics Market: Business Environment Analysis Tools
3.3.1 Porter's Five Forces Analysis
3.3.1.1 Threat of new entrants
3.3.1.2 Bargaining power of suppliers
3.3.1.3 Bargaining power of buyers
3.3.1.4 Competitive rivalry
3.3.1.5 Threat of Substitutes
3.3.2 PESTEL Analysis
3.3.2.1 Political & Legal
3.3.2.2 Economic & Social
3.3.2.3 Technological
3.4 Penetration & Growth Prospect Mapping
3.5 Impact of COVID-19 on the narcolepsy therapeutics market
Chapter 4 Narcolepsy Therapeutics Market: Treatment Analysis
4.1 Narcolepsy Therapeutics Component Market Share Analysis, 2022 & 2030
4.2 Narcolepsy Therapeutics Component Market: Segment Dashboard:
4.3 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Treatment Segment
4.3.1 Narcolepsy with Cataplexy
4.3.1.1 Narcolepsy with cataplexy market, 2018 - 2030 (USD Million)
4.3.2 Narcolepsy without Cataplexy
4.3.2.1 Narcolepsy without cataplexy market, 2018 - 2030 (USD Million)
4.3.3 Secondary Narcolepsy
4.3.3.1 Secondary narcolepsy market, 2018 - 2030 (USD Million)
Chapter 5 Narcolepsy Therapeutics Market: Product Mode Analysis
5.1 Narcolepsy Therapeutics Product Mode Market Share Analysis, 2022 & 2030
5.2 Narcolepsy Therapeutics Product Mode Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Product Mode Segment
5.3.1 Central Nervous System Stimulants
5.3.1.1 Central nervous system stimulants market, 2018 - 2030 (USD Million)
5.3.2 Sodium Oxybate
5.3.2.1 Sodium oxybate market, 2018 - 2030 (USD Million)
5.3.3 Selective Serotonin Reuptake Inhibitor (SSRI)
5.3.3.1 Selective Serotonin Reuptake Inhibitor (SSRI) market, 2018 - 2030 (USD Million)
5.3.4 Tricyclic antidepressants
5.3.4.1 Tricyclic antidepressants market, 2018 - 2030 (USD Million)
5.3.5 Other Narcolepsy Drugs
5.3.5.1 Others market, 2018 - 2030 (USD Million)
Chapter 6 Narcolepsy Therapeutics Market: Regional Analysis
6.1 Narcolepsy Therapeutics Regional Market Share Analysis, 2022 & 2030
6.2 Regional Market Snapshot
6.2. North America
6.2.1. SWOT Analysis
6.2.2. North America Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.2.3. U.S.
6.2.3.1. Key Country Dynamics
6.2.3.2. Target Disease Prevalence
6.2.3.3. Competitive Scenario
6.2.3.4. Regulatory Framework
6.2.3.5. U.S. Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.2.4. Canada
6.2.4.1. Key Country Dynamics
6.2.4.2. Target Disease Prevalence
6.2.4.3. Competitive Scenario
6.2.4.4. Regulatory Framework
6.2.4.5. Canada Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. SWOT Analysis
6.3.2. Europe Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3.3. UK
6.3.3.1. Key Country Dynamics
6.3.3.2. Target Disease Prevalence
6.3.3.3. Competitive Scenario
6.3.3.4. Regulatory Framework
6.3.3.5. UK Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3.4. Germany
6.3.4.1. Key Country Dynamics
6.3.4.2. Target Disease Prevalence
6.3.4.3. Competitive Scenario
6.3.4.4. Regulatory Framework
6.3.4.5. Germany Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3.5. France
6.3.5.1. Key Country Dynamics
6.3.5.2. Target Disease Prevalence
6.3.5.3. Competitive Scenario
6.3.5.4. Regulatory Framework
6.3.5.5. France Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3.6. Italy
6.3.6.1. Key Country Dynamics
6.3.6.2. Target Disease Prevalence
6.3.6.3. Competitive Scenario
6.3.6.4. Regulatory Framework
6.3.6.5. Italy Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3.7. Spain
6.3.7.1. Key Country Dynamics
6.3.7.2. Target Disease Prevalence
6.3.7.3. Competitive Scenario
6.3.7.4. Regulatory Framework
6.3.7.5. Spain Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3.8. Denmark
6.3.8.1. Key Country Dynamics
6.3.8.2. Target Disease Prevalence
6.3.8.3. Competitive Scenario
6.3.8.4. Regulatory Framework
6.3.8.5. Denmark Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3.9. Sweden
6.3.9.1. Key Country Dynamics
6.3.9.2. Target Disease Prevalence
6.3.9.3. Competitive Scenario
6.3.9.4. Regulatory Framework
6.3.9.5. Sweden Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3.10. Norway
6.3.10.1. Key Country Dynamics
6.3.10.2. Target Disease Prevalence
6.3.10.3. Competitive Scenario
6.3.10.4. Regulatory Framework
6.3.10.5. Norway Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. SWOT Analysis
6.4.2. Asia Pacific Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.4.3. Japan
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Competitive Scenario
6.4.3.4. Regulatory Framework
6.4.3.5. Japan Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.4.4. China
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Competitive Scenario
6.4.4.4. Regulatory Framework
6.4.4.5. China Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.4.5. India
6.4.5.1. Key Country Dynamics
6.4.5.2. Target Disease Prevalence
6.4.5.3. Competitive Scenario
6.4.5.4. Regulatory Framework
6.4.5.5. India Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.4.6. Australia
6.4.6.1. Key Country Dynamics
6.4.6.2. Target Disease Prevalence
6.4.6.3. Competitive Scenario
6.4.6.4. Regulatory Framework
6.4.6.5. Australia Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Key Country Dynamics
6.4.7.2. Target Disease Prevalence
6.4.7.3. Competitive Scenario
6.4.7.4. Regulatory Framework
6.4.7.5. Thailand Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.4.8. South Korea
6.4.8.1. Key Country Dynamics
6.4.8.2. Target Disease Prevalence
6.4.8.3. Competitive Scenario
6.4.8.4. Regulatory Framework
6.4.8.5. South Korea Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. SWOT Analysis
6.5.2. Latin America Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.5.3. Brazil
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Competitive Scenario
6.5.3.4. Regulatory Framework
6.5.3.5. Brazil Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Competitive Scenario
6.5.4.4. Regulatory Framework
6.5.4.5. Mexico Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.5.5. Argentina
6.5.5.1. Key Country Dynamics
6.5.5.2. Target Disease Prevalence
6.5.5.3. Competitive Scenario
6.5.5.4. Regulatory Framework
6.5.5.5. Argentina Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.6. MEA
6.6.1. SWOT Analysis
6.6.2. MEA Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.6.3. South Africa
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Competitive Scenario
6.6.3.4. Regulatory Framework
6.6.3.5. South Africa Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.6.4. Saudi Arabia
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Competitive Scenario
6.6.4.4. Regulatory Framework
6.6.4.5. Saudi Arabia Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.6.5. UAE
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Competitive Scenario
6.6.5.4. Regulatory Framework
6.6.5.5. UAE Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.6.6. Kuwait
6.6.6.1. Key Country Dynamics
6.6.6.2. Target Disease Prevalence
6.6.6.3. Competitive Scenario
6.6.6.4. Regulatory Framework
6.6.6.5. Kuwait Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company Profiles
7.2.1 Teva Pharmaceutical Industries Ltd.
7.2.1.1 Company overview
7.2.1.2 Financial performance
7.2.1.3 Product benchmarking
7.2.1.4 Strategic initiatives
7.2.2 Jazz Pharmaceuticals, Inc.
7.2.2.1 Company overview
7.2.2.2 Financial performance
7.2.2.3 Product benchmarking
7.2.2.4 Strategic initiatives
7.2.3 Harmony Biosciences
7.2.3.1 Company overview
7.2.3.2 Financial performance
7.2.3.3 Product benchmarking
7.2.3.4 Strategic initiatives
7.2.4 Novartis AG
7.2.4.1 Company overview
7.2.4.2 Financial performance
7.2.4.3 Product benchmarking
7.2.4.4 Strategic initiatives
7.2.5 Rhodes Pharmaceuticals L.P.
7.2.5.1 Company overview
7.2.5.2 Financial performance
7.2.5.3 Product benchmarking
7.2.5.4 Strategic initiatives
7.2.6 Janssen Global Services, LLC
7.2.6.1 Company overview
7.2.6.2 Financial performance
7.2.6.3 Product benchmarking
7.2.6.4 Strategic initiatives
7.2.7 Eli Lilly and Company
7.2.7.1 Company overview
7.2.7.2 Financial performance
7.2.7.3 Product benchmarking
7.2.7.4 Strategic initiatives
List of Tables
Table 1 North America narcolepsy therapeutics market, by country, 2018 - 2030 (USD Million)
Table 2 North America narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 3 North America narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 4 U.S. narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 5 U.S. narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 6 Canada narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 7 Canada narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 8 Europe narcolepsy therapeutics market, by country, 2018 - 2030 (USD Million)
Table 9 Europe narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 10 Europe narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 11 UK narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 12 UK narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 13 Germany narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 14 Germany narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 15 France narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 16 France narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 17 Italy narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 18 Italy narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 19 Spain narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 20 Spain narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 21 Denmark narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 22 Denmark narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 23 Sweden narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 24 Sweden narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 25 Norway narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 26 Norway narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 27 Asia Pacific narcolepsy therapeutics market, by country, 2018 - 2030 (USD Million)
Table 28 Asia Pacific narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 29 Asia Pacific narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 30 Japan narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 31 Japan narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 32 China narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 33 China narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 34 India narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 35 India narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 36 Australia narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 37 Australia narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 38 South Korea narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 39 South Korea narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 40 Thailand narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 41 Thailand narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 42 Latin America narcolepsy therapeutics market, by country, 2018 - 2030 (USD Million)
Table 43 Latin America narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 44 Latin America narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 45 Brazil narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 46 Brazil narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 47 Mexico narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 48 Mexico narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 49 Argentina narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 50 Argentina narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 51 MEA narcolepsy therapeutics market, by country, 2018 - 2030 (USD Million)
Table 52 MEA narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 53 MEA narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 54 South Africa narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 55 South Africa narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 56 Saudi Arabia narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 58 UAE narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 59 UAE narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 60 Kuwait narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 61 Kuwait narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Value chain-based sizing & forecasting
Fig. 4 QFD modeling for market share assessment
Fig. 5 Market Summary, 2022
Fig. 6 Market Trends & Outlook
Fig. 7 Market Segmentation & Scope
Fig. 8 Market driver relevance analysis (Current & future impact)
Fig. 9 Market restrain relevance analysis (Current & future impact)
Fig. 10 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 11 Porter’s Five Forces Analysis
Fig. 12 Narcolepsy therapeutics market type outlook key takeaways
Fig. 13 Narcolepsy therapeutics market: Type movement analysis
Fig. 14 Global narcolepsy with cataplexy market, 2018 - 2030 (USD Million)
Fig. 15 Global narcolepsy without cataplexy market, 2018 - 2030 (USD Million)
Fig. 16 Global secondary narcolepsy market, 2018 - 2030 (USD Million)
Fig. 17 Narcolepsy therapeutics market product outlook key takeaways
Fig. 18 Narcolepsy therapeutics market: Product movement analysis
Fig. 19 Global central nervous system stimulants market, 2018 - 2030 (USD Million)
Fig. 20 Global sodium Oxybate market, 2018 - 2030 (USD Million)
Fig. 21 Global selective serotonin reuptake inhibitor market, 2018 - 2030 (USD Million)
Fig. 22 Global tricyclic antidepressants market, 2018 - 2030 (USD Million)
Fig. 23 Global other narcolepsy drugs market, 2018 - 2030 (USD Million)
Fig. 24 Regional marketplace: Key takeaways
Fig. 25 Regional marketplace: Key takeaways
Fig. 26 North America narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Key country dynamics
Fig. 28 U.S. narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Key country dynamics
Fig. 30 Canada narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Europe narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Key country dynamics
Fig. 33 UK narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Key country dynamics
Fig. 35 Germany narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Key country dynamics
Fig. 37 France narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Key country dynamics
Fig. 39 Spain narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Key country dynamics
Fig. 41 Italy narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Key country dynamics
Fig. 43 Denmark narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Key country dynamics
Fig. 45 Sweden narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Key country dynamics
Fig. 47 Norway narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Rest of Europe narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Asia Pacific narcolepsy therapeutics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Japan narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 China narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 India narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 South Korea narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 South Korea reimbursement scenario
Fig. 59 Key country dynamics
Fig. 60 Australia narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Thailand narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Rest of Asia Pacific narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Latin America narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Brazil narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Mexico narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Argentina narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Rest of Latin America narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 MEA narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 South Africa narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Saudi Arabia narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 UAE narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Kuwait narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Rest of MEA narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key company categorization
Fig. 83 Company categorization
Fig. 84 Company market share analysis, 2022
Fig. 85 Strategic Framework

Companies Mentioned

  • Teva Pharmaceutical Industries Ltd.
  • Jazz Pharmaceuticals, Inc.
  • Harmony Biosciences
  • Novartis AG
  • Rhodes Pharmaceuticals L.P.
  • Janssen Global Services, LLC
  • Eli Lilly and Company

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedAugust 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 3.28 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.01 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned7

Related Topics

Related Reports

Narcolepsy Therapeutics - Global Strategic Business Report - Product Image

Narcolepsy Therapeutics - Global Strategic Business Report

  • Report
  • 363 Pages
  • Global
From
Narcolepsy Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028 - Product Image

Narcolepsy Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028

  • Report
  • 190 Pages
  • Global
From
2024 Global Forecast for Narcolepsy Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Narcolepsy Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
Narcolepsy Drugs Market by Type, Therapeutics Type - Global Forecast 2025-2030 - Product Image

Narcolepsy Drugs Market by Type, Therapeutics Type - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Global Narcolepsy Drugs Market (By Therapeutic Type, Disease Type, End User, Regional Analysis), Pipeline Analysis, Key Company Profiles and Recent Developments - Forecast to 2030 - Product Image

Global Narcolepsy Drugs Market (By Therapeutic Type, Disease Type, End User, Regional Analysis), Pipeline Analysis, Key Company Profiles and Recent Developments - Forecast to 2030

  • Report
  • 172 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.